 
HUGO ARNALDO GONZALEZ VELOZO
Associated Investigator
Universidad San Sebastián
Santiago, Chile
Cancer Biology, Metastasis, tumor-immune crosstalk, Bioinformatics, Cancer System Biology.
- 
Tecnologia Medica, UNIVERSIDAD DE TALCA. Chile, 2005
- 
Tecnologo Medico, UNIVERSIDAD DE TALCA. Chile, 2005
- 
Molecular Biology, UNIVERSIDAD ANDRES BELLO. Chile, 2013
- 
PhD Candidate and Professor Full TimeUNIVERSIDAD ANDRES BELLO Biological Sciences Santiago, Chile 2008 - 2010 
- 
PhD Candidate Full TimeFUNDACION CIENCIA PARA LA VIDA Santiago, Chile 2009 - 2014 
- 
POSTDOCTORAL FELLOW Full TimeUNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO, Estados Unidos 2015 - 2022 
- 
Assistant Adjunct Professor Full TimeUNIVERSITY OF CALIFORNIA SAN FRANCISCO San Francisco, Estados Unidos 2022 - At present 
- 
Associate Professor Full TimeFundacion Ciencia y Vida Santiago, Chile 2023 - At present 
- 
Investigador Asociado Full TimeUNIVERSIDAD SAN SEBASTIAN Centro Basal Ciencia y Vida Santiago, Chile 2025 - At present 
- 
Postdoctoral Fellow Full TimeUniversity of California San Francisco San Francisco, Estados Unidos 2015 - 2022 
- 
PhD candidate and postdoctoral researcher Full TimeFundacion Ciencia y Vida Santiago, Chile 2009 - 2014 
- 
Teaching assistant Full TimeUniversidad Andres Bello Santiago, Chile 2008 - 2010 
- 
Assistant Adjunct Professor Full TimeUniversity of California San Francisco San Franciso, Estados Unidos 2022 - At present 
- 
Associate Professor Full TimeFundacion Ciencia y vida Santiago, Chile 2023 - At present 
- 
Investigador Asociado Centro Basal Ciencia y Vida Full TimeUniversidad San Sebastian Santiago, Chile 2025 - At present 
MENTORING AND TEACHING EXPERIENCE
Mentoring (Alumni)
• Master program mentor for Merel van Gogh, University of Utrecht, Netherlands. Current appointment: PhD candidate at University of Zurich.
• Master program Mentor for Tamara Verbeek, University of Utrecht, Netherlands. Current appointment: PhD student at University of Utrecht.
• Mentor for Wenbin Mei, Peking University, China (intern). Current appointment: PhD candidate at Rockefeller University.
• Mentor for Isabella Robles, University of California Berkeley (intern). Current appointment: Stanford University.
• Mentor for Sandhya Kalavacherla, Massachusetts Institute of Technology (MIT) (intern). Current appointment: University of California San Diego.
• Mentor for Stephen Georgiou, University of California Berkeley (intern). Current appointment: University of California San Francisco.
• Mentor for Ankitha Nanjaraj, University of California San Francisco (Research Associated). Current appointment: Sangamo Therapeutics Inc.
Collaborations with biopharmaceutical companies in the USA.
• Company: 3T BIOSCIENCES INC.
Location: South San Francisco, CA, USA.
Dates of collaboration: (12/2020-12/2021).
Role: Scientific advisor in developing new ex-vivo systems for testing next-generation T cell therapies against solid cancers.
    
• Company: SENTI BIOSCIENCES, INC.
Location: South San Francisco, CA, USA.
Dates of collaboration: (08/2021-Present).
Role: Scientific advisor and collaborator in developing next-generation NK cell therapies for carcinomas.
- 
BECA DE POSTDOCTORADO EN EL EXTRANJERO BECAS CHILECONICYT Chile, 2015 Scholarship to perform postdoctoral training in an international institution. 
- 
BECA DE DOCTORADO EN CHILECONICYT Chile, 2010 Scholarship for Ph.D. studies in Chile. 
- 
BECAS DE TÉRMINO DE TESIS DOCTORALCONICYT Chile, 2012 Scholarship to fund the completion of doctoral dissertation. 
- 
Summa Cum Laude Distinction for doctoral dissertation.UNIVERSIDAD ANDRES BELLO Chile, 2013 Doctoral dissertation evaluated with the highest distinction. 
- 
Elected Member of the UCSF Hellen Diller Family Comprehensive Cancer CenterUniversity of California San Francisco Estados Unidos, 2023 Elected member of the Breast Oncology Program at the UCSF Hellen Diller Family Comprehensive Cancer Center since July 2023 
- 
Elected member of the UCSF ImmunoX faculty teamUniversity of California San Francisco Chile, 2024 Elected member of the UCSF ImmunoX faculty team since August 2024. 
- 
Fondecyt number 1230021ANID Chile, 2023 Title: Molecular determinants of tumor cell fitness in human brain metastases: connecting transcriptional regulators with metastatic phenotypes Role: Principal Investigator Years: 2023-2027 Total Direct Cost per year: $71,250.00 Description: This study is focused on understanding the gene regulatory networks, and identifying the cis-regulatory elements and transcription factors that mediate the fitness of human metastatic tumor cells. 
- 
Conque Cancer NowCONCERN FOUNDATION Estados Unidos, 2024 The Concern Foundation (USA) Title: Reprogramming of the Metastatic Niche by Tumor Cell-Derived Factors Role: Principal Investigator Years: 2024-2026 Total Direct Cost per year: $75,000.00 Description: This study aims to validate mechanistically how specific factors secreted by metastatic tumor cells reprogram the composition and activation state of non-malignant cells at the metastatic site. Here we combine high dimensional flow cytometry analyses and molecular cancer biology, with syngeneic system of breast cancer metastasis. 
- 
Grant number BCRF-23-183 (USA).The Breast Cancer Research Foundation. Estados Unidos, 2024 Title: Eradicating metastatic disease by enhancing breast cancer treatment and anti-tumor immunity Role: Co-Investigator with Professor Valerie Weaver (lead PI) Years: 2023-2024 (renewable annually) Total Direct Cost per year: $187,500.00 Description: This study led by Professor Valerie Weaver aims to study the interface between innate immunity, extracellular matrix and metastatic progression in breast cancer metastasis, my contribution in on studies related to brain metastasis colonization. 
| Dopamine receptor D5 expressed on dendritic cells promotes CD4+T-cell-mediated autoinununity | 
| Stimulation of dopamine receptor D3 expressed on CD4(+) T-cells favours Th1 immunity | 
| Role of dopamine receptors expressed on CD4+ T-cell and on dendritic cells in the development of autoimmune response and in cellular mechanisms involved in the physiopathology of multiple sclerosis | 
| Proyecto de inicio a la investigación para estudiantes de doctorado=> "Papel de los receptores de dopamina expresados en células T CD4+ en el desarrollo de la enfermedad de Parkinson". | 
| Role of dopamine receptors on the T-cell mediated immunity | 
| Financiamiento Basal para Centros Científicos y Tecnológicos de Excelencia | 
| Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases | 
| T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases | 
 
Rodrigo Pacheco
Associate Investigator; Head of the Laboratory of Neuroimmunology
Fundación Ciencia para la Vida
Santiago, Chile
 
Patricio Rojas
Assistant Professor
Departamento de Biologia
UNIVERSIDAD DE SANTIAGO DE CHILE
Santiago, Chile
 
Fabiola Osorio
Associate Professor
Programa Disciplinario de Inmunologia
Universidad de Chile
Santiago, Chile
 
Pablo Díaz
Professional/Scientific advisor
Scientific Affairs
Instituto de Salud Públida de Chile
santiago, Chile
 
Andres Herrada
Principal Investigator
Instituto de Ciencias Biomédicas
Universidad Autónoma de Chile
Talca, Chile
 
Francisco Contreras
Investigador en área de Investigación y Desarrollo de productos biológicos
Centrovet Ltda.
Santiago, Chile
 
Claudio Figueroa
Profesor Asistente
Ciencias Biológicas y Quimicas
Universidad San Sebastian
Santiago, Chile
 
Andro Montoya
Docente de Laboratorio de Biología Celular
Instituto de Ciencias Naturales
Universidad de Las Américas
Santiago, Chile
 
Valentina Ugalde
Lab Manager
Laboratorio de Neuroinmunología
Fundación Ciencia & Vida
Santiago, Chile
 
HUGO GONZALEZ
Associated Investigator
Centro Basal Ciencia y Vida
Universidad San Sebastián
Santiago, Chile
 
Estefania Lopez
Lab Manger /Asistente de investigacion
Neurociencias
Universidad de Chile
Santiago, Chile
 Portal del Investigador
						 Portal del Investigador
						
					 
 
